Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06587438

Effect of CGM on Glucose Control in Non-insulin-treated Patients with Type 2 Diabetes Mellitus

Effects of COntinuous Glucose MoNitoring Versus Usual Care on GlycEmic Control in Non-insulin-tReated Adults with Type 2 Diabetes:a Multi-center Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Sinocare · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The clinical value of CGM for diabetic patients undergoing insulin therapy has been widely recognized, but the evidence-based support for its use in non-insulin-treated type 2 diabetic patients remains insufficient. The primary objective of this study is to evaluate the effect of real-time continuous glucose monitoring (CGM) compared with self-monitoring of blood glucose on glycemic control in adults with non-insulin treated type 2 diabetes.

Conditions

Interventions

TypeNameDescription
DEVICESinocare iCan I3 CGMReal-time Continuous glucose monitoring
DEVICESinocare jinzhi+Blood glucose meterSelf-monitoring of blood glucose

Timeline

Start date
2024-10-15
Primary completion
2025-09-30
Completion
2026-03-31
First posted
2024-09-19
Last updated
2024-09-19

Source: ClinicalTrials.gov record NCT06587438. Inclusion in this directory is not an endorsement.